Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study

Author:

King A. B.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference5 articles.

1. Towards peakless, reproducible and long-acting insulins: an assessment of the basal analogues based on isoglycaemic clamp studies;Heise;Diabetes Obes Metab,2007

2. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study;Porcellati;Diabetes Care,2007

3. Insulin detemir in combination with OADs improves glycaemic control and reduces hypoglycaemia, without weight gain, in type 2 patients previously treated with OADs plus bedtime NPH or insulin glargine: results from the PREDICTIVE™ study (P921);King;Diabet Med,2006

4. A randomized, 52 week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes;Rosenstock;Diabetologia,2008

5. Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a treat-to-target study in people with type 2 diabetes;Raskin;Diabet Med,2006

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. References;Randomised Clinical Trials;2021-05-24

2. Mean basal insulin dose is 0.2 U/kg/d at near normal glycaemia for type 1 or 2 diabetes on continuous subcutaneous insulin infusion or once‐nightly basal insulin;Diabetes, Obesity and Metabolism;2021-01-29

3. Detemir vs Glargine: Comparison of Inpatient Glycemic Control;Journal of Osteopathic Medicine;2019-02-01

4. Cumulative References;Sample Sizes for Clinical, Laboratory and Epidemiology Studies;2018-06-01

5. Non-Inferiority and Equivalence;Sample Sizes for Clinical, Laboratory and Epidemiology Studies;2018-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3